Current and emerging therapies for the treatment of myasthenia gravis
Renato Mantegazza, Silvia Bonanno, Giorgia Camera, Carlo AntozziDepartment of Neuromuscular Diseases and Neuroimmunology, Fondazione Istituto Neurologico Carlo Besta, Milan, ItalyAbstract: Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromusc...
Enregistré dans:
Auteurs principaux: | Renato Mantegazza, Silvia Bonanno, Giorgia Camera, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/42d9506f1cd747d1880b6e7e5e5b2e37 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
par: Chad Heatwole, et autres
Publié: (2008) -
Association Between Myasthenia Gravis and Memory: A Systematic Review and Meta-Analysis
par: Xiaoling Zhou, et autres
Publié: (2021) -
Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort
par: Jianquan Shi, et autres
Publié: (2021) -
Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study
par: Sijia Zhao, et autres
Publié: (2021) -
Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis
par: Yangyu Huang, et autres
Publié: (2021)